{"id":"sertraline-hcl","safety":{"commonSideEffects":[{"rate":"20-26%","effect":"Nausea"},{"rate":"12-18%","effect":"Diarrhea"},{"rate":"13-24%","effect":"Headache"},{"rate":"8-11%","effect":"Tremor"},{"rate":"10-16%","effect":"Insomnia"},{"rate":"15-25%","effect":"Sexual dysfunction"},{"rate":"5-13%","effect":"Somnolence"},{"rate":"9-16%","effect":"Dry mouth"}]},"_chembl":null,"_dailymed":{"setId":"a5c49e6e-b8e0-4a75-99e6-b88e323ce653","title":"SERTRALINE HCL (SERTRALINE) CAPSULE [AMNEAL PHARMACEUTICALS NY LLC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Sertraline is a selective serotonin reuptake inhibitor (SSRI) that blocks the serotonin transporter protein, preventing the reabsorption of serotonin from the synaptic cleft back into presynaptic neurons. This increases serotonin concentration in the synapse, enhancing neurotransmission and improving mood regulation. The mechanism is thought to underlie its efficacy in treating depression, anxiety disorders, and related conditions.","oneSentence":"Sertraline selectively inhibits the reuptake of serotonin at the neuronal synapse, increasing serotonin availability in the brain.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:52:28.553Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Major depressive disorder"},{"name":"Obsessive-compulsive disorder"},{"name":"Panic disorder"},{"name":"Post-traumatic stress disorder"},{"name":"Social anxiety disorder"},{"name":"Generalized anxiety disorder"},{"name":"Premenstrual dysphoric disorder"}]},"trialDetails":[{"nctId":"NCT07478796","phase":"PHASE4","title":"TDM-Guided Treatment With SSRIs in Hospitalized Adults and Children","status":"RECRUITING","sponsor":"Poznan University of Medical Sciences","startDate":"2025-04-03","conditions":"Depression - Major Depressive Disorder, Depressive Episodes","enrollment":180},{"nctId":"NCT07015944","phase":"NA","title":"Moving on After Breast Cancer Trial for Depressed Breast Cancer Survivors in Pakistan","status":"RECRUITING","sponsor":"Pakistan Institute of Living and Learning","startDate":"2025-06-13","conditions":"Major Depressive Disorder (MDD), Breast Cancer Survivor","enrollment":26376},{"nctId":"NCT06408246","phase":"PHASE2","title":"ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression","status":"RECRUITING","sponsor":"Stanford University","startDate":"2026-03-03","conditions":"Depression","enrollment":162},{"nctId":"NCT07139834","phase":"PHASE1","title":"Pattern Separation in Major Depressive Disorder","status":"NOT_YET_RECRUITING","sponsor":"Jeffrey Miller","startDate":"2026-04","conditions":"Major Depressive Disorder (MDD)","enrollment":30},{"nctId":"NCT03511118","phase":"","title":"Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants","status":"RECRUITING","sponsor":"Duke University","startDate":"2018-10-04","conditions":"Lactating Women on Select DOI, Breastfed Infants of Mothers on Select DOI","enrollment":1600},{"nctId":"NCT04183205","phase":"PHASE4","title":"Predicting SSRI Efficacy in Veterans With PTSD","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2019-09-11","conditions":"Posttraumatic Stress Disorder, Major Depressive Disorder","enrollment":26},{"nctId":"NCT07387120","phase":"","title":"Sertraline and the Risk of Serious Adverse Events","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2008-01","conditions":"Chronic Kidney Disease (CKD), Elderly, Outpatient","enrollment":6893},{"nctId":"NCT05814640","phase":"PHASE1, PHASE2","title":"Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)","status":"RECRUITING","sponsor":"First Affiliated Hospital of Chongqing Medical University","startDate":"2023-02-20","conditions":"Depression, Sequestra","enrollment":520},{"nctId":"NCT05603104","phase":"PHASE3","title":"Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure","status":"RECRUITING","sponsor":"Dr. Inge Winter","startDate":"2025-04-27","conditions":"Schizophrenia and Related Disorders, Major Depressive Disorder, Bipolar Depression","enrollment":1254},{"nctId":"NCT04747314","phase":"PHASE2, PHASE3","title":"Treating Negative Affect in Low Back Pain Patients","status":"COMPLETED","sponsor":"Ajay Wasan, MD, Msc","startDate":"2021-03-31","conditions":"Chronic Low Back Pain, Negative Affectivity","enrollment":308},{"nctId":"NCT05528224","phase":"NA","title":"Effect of SC-ICBT for Adults With OCD：A Three-Arm Randomized Controlled Trial","status":"TERMINATED","sponsor":"Shanghai Mental Health Center","startDate":"2022-09-01","conditions":"Obsessive-Compulsive Disorder","enrollment":46},{"nctId":"NCT07318181","phase":"NA","title":"Building Ukraine's Strength in PTSD Treatment and Research","status":"RECRUITING","sponsor":"University of Luxembourg","startDate":"2026-01-01","conditions":"Post Traumatic Stress Disorder, Post Traumatic Stress Disorder PTSD, Post-Traumatic Stress Disorder, PTSD","enrollment":120},{"nctId":"NCT06659094","phase":"NA","title":"Reducing Maximal Support in OCD: Efficacy of Stepped-Care Online CBT","status":"COMPLETED","sponsor":"Shanghai Mental Health Center","startDate":"2023-08-21","conditions":"Obsessive Compulsive Disorder (OCD)","enrollment":95},{"nctId":"NCT07328373","phase":"","title":"Neurobiological and Genomic Predictors of Relapse in Depression","status":"RECRUITING","sponsor":"Mehmet Kemal Arikan","startDate":"2025-01-01","conditions":"Healthy, Major Depressive Disorder (MDD)","enrollment":204},{"nctId":"NCT06965569","phase":"PHASE1","title":"Multiple Ascending Dose Phase 1 Study of ALA-3000","status":"COMPLETED","sponsor":"Alar Pharmaceuticals Inc.","startDate":"2025-04-21","conditions":"Treatment Resistant Depression","enrollment":37},{"nctId":"NCT06384209","phase":"NA","title":"The Friendship Bench Plus Trial","status":"RECRUITING","sponsor":"University of Bern","startDate":"2025-06-26","conditions":"Major Depressive Disorder, Severe Depressive Episode Without Psychotic Symptoms","enrollment":296},{"nctId":"NCT00262470","phase":"PHASE1, PHASE2","title":"Treatment of Orthostatic Intolerance","status":"ACTIVE_NOT_RECRUITING","sponsor":"Satish R. Raj","startDate":"1997-04","conditions":"Tachycardia, Chronic Orthostatic Intolerance","enrollment":150},{"nctId":"NCT05973786","phase":"PHASE3","title":"The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.","status":"RECRUITING","sponsor":"Dr. Inge Winter","startDate":"2025-02-11","conditions":"Bipolar Depression","enrollment":418},{"nctId":"NCT07192367","phase":"PHASE4","title":"Comparison of the Effectiveness Level of Virtual Reality Exposure Therapy With Sertraline Treatment in Social Anxiety Disorder","status":"RECRUITING","sponsor":"Emine Kanmaz","startDate":"2024-11-15","conditions":"Social Anxiety Disorder","enrollment":56},{"nctId":"NCT00285935","phase":"NA","title":"Cellular Aging and Neurobiology of Depression Study","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2010-12-16","conditions":"Major Depressive Disorder","enrollment":228},{"nctId":"NCT07185464","phase":"NA","title":"Efficacy and Safety of Transcranial Alternating Current Stimulation (tACS) in Adolescents With First-episode Depression Who Are Drug-naive: A Randomized, Double-blind, Controlled Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Chongqing Medical University","startDate":"2025-10-01","conditions":"Depression - Major Depressive Disorder","enrollment":30},{"nctId":"NCT05537584","phase":"PHASE4","title":"SMART Trial to Predict Anhedonia Response to Antidepressant Treatment","status":"COMPLETED","sponsor":"Mclean Hospital","startDate":"2022-09-30","conditions":"Major Depressive Disorder","enrollment":133},{"nctId":"NCT07161492","phase":"NA","title":"A Study on Functional Connectome and rTMS Intervention of Cognitive Flexibility Impairment in Patients With Major Depressive Disorder","status":"NOT_YET_RECRUITING","sponsor":"Second Xiangya Hospital of Central South University","startDate":"2025-09","conditions":"Depressive Disorder, Major, Cognitive Impairment","enrollment":182},{"nctId":"NCT06591091","phase":"PHASE2","title":"Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression","status":"NOT_YET_RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2025-09","conditions":"Depression","enrollment":80},{"nctId":"NCT06746441","phase":"PHASE2","title":"Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity Markers","status":"COMPLETED","sponsor":"Khyber Medical University Peshawar","startDate":"2024-12-01","conditions":"Major Depressive Disorder","enrollment":60},{"nctId":"NCT06698666","phase":"PHASE3","title":"Efficacy of Statins Among Major Depressive Disorder","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2022-10-01","conditions":"Major Depressive Disorder, MDD","enrollment":145},{"nctId":"NCT06001021","phase":"NA","title":"Cognitive Behavioral Couple Therapy for Perinatal Distress","status":"COMPLETED","sponsor":"Sameera Shafiq","startDate":"2023-08-15","conditions":"Perinatal Depression, Perinatal Anxiety","enrollment":96},{"nctId":"NCT07120880","phase":"PHASE3","title":"Efficacy of Chronotherapeutic Combination for Major Depressive Episode With Insomnia","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-09","conditions":"Major Depressive Disorder (MDD) With Insomnia","enrollment":184},{"nctId":"NCT06942494","phase":"NA","title":"Effect of a Family-Based CBT Self-Help Intervention for Adolescents With OCD","status":"RECRUITING","sponsor":"Shanghai Mental Health Center","startDate":"2025-04-30","conditions":"Obsessive - Compulsive Disorder","enrollment":88},{"nctId":"NCT06894680","phase":"NA","title":"Integrating Depression Care Into HIV Services for Older People With HIV Using a Stepped Care, Task-Sharing Approach.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Royal Society of Tropical Medicine and Hygiene","startDate":"2025-03-24","conditions":"Older Adults (50-90 Years), Depression","enrollment":120},{"nctId":"NCT06081348","phase":"PHASE2","title":"Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders","status":"RECRUITING","sponsor":"Holland Bloorview Kids Rehabilitation Hospital","startDate":"2024-09-16","conditions":"Neurodevelopmental Disorders, Autism, Autism Spectrum Disorder","enrollment":130},{"nctId":"NCT05273996","phase":"PHASE4","title":"Predictors of Cognitive Outcomes in Geriatric Depression","status":"ACTIVE_NOT_RECRUITING","sponsor":"David Steffens","startDate":"2021-09-28","conditions":"Major Depressive Disorder, Neuroticism, Cognitive Change","enrollment":75},{"nctId":"NCT06955845","phase":"NA","title":"Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) Therapy Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in the Treatment of Post-Traumatic Stress Disorder","status":"ACTIVE_NOT_RECRUITING","sponsor":"Asad Ullah Jan","startDate":"2025-05-06","conditions":"PTSD, PTSD - Post Traumatic Stress Disorder","enrollment":60},{"nctId":"NCT03222570","phase":"PHASE2","title":"An Adaptive Algorithm-Based Approach to Treatment for Adolescent Depression","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2018-02-26","conditions":"Depressive Disorder","enrollment":90},{"nctId":"NCT02813447","phase":"NA","title":"Safety of Anti-Depressant for Chronic Obstructive Pulmonary Disease (SAD-COPD)","status":"TERMINATED","sponsor":"Duke University","startDate":"2016-08","conditions":"COPD, Anxiety, Depression","enrollment":13},{"nctId":"NCT07025590","phase":"NA","title":"Effect of Exercise on Tapering Antipsychotics in Patients With Psycho-cardiological Disease(EXTRA-study)","status":"RECRUITING","sponsor":"Guangdong Provincial People's Hospital","startDate":"2025-04-22","conditions":"Cardiovascular Diseases (CVD), Depression Anxiety Disorder","enrollment":106},{"nctId":"NCT04124614","phase":"PHASE3","title":"Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSD","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2019-10-17","conditions":"Post Traumatic Stress Disorder","enrollment":450},{"nctId":"NCT02777372","phase":"PHASE4","title":"Stress & Premenstrual Symptoms Study","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2016-04-01","conditions":"PMDD, Stress, Mood","enrollment":84},{"nctId":"NCT07011693","phase":"PHASE4","title":"Switching Medication and Augmentation Strategies for SSRI-Resistant Adolescent Depression（SMART-I)","status":"NOT_YET_RECRUITING","sponsor":"Xinyu Zhou","startDate":"2025-06-20","conditions":"Major Depressive Disorder (MDD)","enrollment":400},{"nctId":"NCT06704594","phase":"PHASE4","title":"Allopregnanolone and Dynamic GABA-A Receptor Plasticity in Selective Serotonin Reuptake Inhibitor Responsive Premenstrual Dysphoric Disorder","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-05-14","conditions":"Premenstrual Dysphoric Disorder (PMDD)","enrollment":288},{"nctId":"NCT04174170","phase":"PHASE3","title":"Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress Disorder","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2019-10-30","conditions":"Post Traumatic Stress Disorder","enrollment":591},{"nctId":"NCT04539951","phase":"PHASE2","title":"Pragmatic Trial of Obsessive-compulsive Disorder","status":"RECRUITING","sponsor":"Shanghai Mental Health Center","startDate":"2020-09-22","conditions":"Obsessive-Compulsive Disorder","enrollment":1600},{"nctId":"NCT05002309","phase":"PHASE2","title":"Treatment Interrupts Depression Early","status":"RECRUITING","sponsor":"Nova Scotia Health Authority","startDate":"2021-12-02","conditions":"Depression","enrollment":100},{"nctId":"NCT02752542","phase":"PHASE4","title":"Personalized Indications for CBT and Antidepressants in Treating Depression","status":"RECRUITING","sponsor":"Nova Scotia Health Authority","startDate":"2016-10-31","conditions":"Major Depressive Disorder, Persistent Depressive Disorder","enrollment":80},{"nctId":"NCT04597190","phase":"PHASE4","title":"Sequenced Treatment Effectiveness for Posttraumatic Stress","status":"COMPLETED","sponsor":"University of Washington","startDate":"2020-06-01","conditions":"PTSD","enrollment":700},{"nctId":"NCT02417064","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-08-10","conditions":"Treatment-resistant Depression","enrollment":346},{"nctId":"NCT03434041","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2018-05-25","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":252},{"nctId":"NCT02493868","phase":"PHASE3","title":"A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-10-01","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":719},{"nctId":"NCT02418585","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-08-07","conditions":"Treatment-resistant Depression","enrollment":236},{"nctId":"NCT02497287","phase":"PHASE3","title":"A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-09-30","conditions":"Treatment-resistant Depression","enrollment":802},{"nctId":"NCT02422186","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-08-20","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":139},{"nctId":"NCT03321526","phase":"PHASE2","title":"A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-12-12","conditions":"Depressive Disorder, Major","enrollment":107},{"nctId":"NCT03852160","phase":"PHASE3","title":"A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant Depression","status":"WITHDRAWN","sponsor":"Janssen-Cilag International NV","startDate":"2019-12-01","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":""},{"nctId":"NCT06796946","phase":"EARLY_PHASE1","title":"Deprescription of Antidepressants in Primary Care (DAPriCare)","status":"NOT_YET_RECRUITING","sponsor":"University of Huelva","startDate":"2025-04","conditions":"Deprescription, Antidepressants","enrollment":325},{"nctId":"NCT04278404","phase":"","title":"Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)","status":"RECRUITING","sponsor":"Duke University","startDate":"2020-03-05","conditions":"Coronavirus Infection (COVID-19), Pulmonary Arterial Hypertension, Urinary Tract Infections in Children","enrollment":5000},{"nctId":"NCT06840379","phase":"NA","title":"Effect of Sertraline on Inflammation in Hemodialysis Patients with Depression: a Randomized Controlled Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nishtar Medical University","startDate":"2024-10-15","conditions":"Inflamation, Hemodialysis, End Stage Renal Disease on Hemodialysis (Diagnosis)","enrollment":62},{"nctId":"NCT04637620","phase":"PHASE2","title":"NMDA Modulation in Major Depressive Disorder","status":"RECRUITING","sponsor":"China Medical University Hospital","startDate":"2017-06-01","conditions":"Major Depressive Disorder","enrollment":90},{"nctId":"NCT05683223","phase":"NA","title":"Neural Markers of Treatment Mechanisms and Prediction of Treatment Outcomes in Social Anxiety","status":"RECRUITING","sponsor":"Boston University Charles River Campus","startDate":"2023-05-26","conditions":"Social Anxiety Disorder","enrollment":240},{"nctId":"NCT04598230","phase":"PHASE3","title":"Partners in Caring for Anxious Youth","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ann & Robert H Lurie Children's Hospital of Chicago","startDate":"2021-02-09","conditions":"Anxiety, Separation, Anxiety, Generalized, Anxiety, Social","enrollment":468},{"nctId":"NCT00667121","phase":"","title":"Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2011-03-16","conditions":"Breast Cancer, Depression, Hot Flashes","enrollment":88},{"nctId":"NCT06827431","phase":"PHASE3","title":"The Research of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression","status":"NOT_YET_RECRUITING","sponsor":"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.","startDate":"2025-02-14","conditions":"Major Depressive Disorder (MDD)","enrollment":770},{"nctId":"NCT06778824","phase":"NA","title":"Neuroregulators for the Treatment of Diseases Associated With Esophageal-brain-gut Axis Communication Abnormalities.","status":"RECRUITING","sponsor":"Hualien Tzu Chi General Hospital","startDate":"2024-04-02","conditions":"Gut-Brain Disorders, GERD Without Erosive Esophagitis","enrollment":610},{"nctId":"NCT05892744","phase":"PHASE4","title":"Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression","status":"RECRUITING","sponsor":"University of Texas at Austin","startDate":"2023-09-30","conditions":"Major Depressive Disorder, Chronic Major Depression, Recurrent","enrollment":50},{"nctId":"NCT02431845","phase":"NA","title":"Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive Disorder","status":"RECRUITING","sponsor":"Severance Hospital","startDate":"2013-01-01","conditions":"Obsessive-Compulsive Disorder","enrollment":200},{"nctId":"NCT06725771","phase":"NA","title":"A Non-randomized Controlled Trial Was Conducted to Observe the Improvement in the Level of HAMA in Patients With Generalized Anxiety Disorder During the 6-week Period of Oral Treatment With Chaihu Jia Longgu Muli Tang (Bupleurum Plus Dragon Bone and Oyster Shell Decoction) Combined With Sertraline.","status":"COMPLETED","sponsor":"Lin Xiaoqian","startDate":"2022-09-01","conditions":"Generalised Anxiety Disorder","enrollment":205},{"nctId":"NCT04446039","phase":"","title":"Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea","status":"COMPLETED","sponsor":"Pfizer","startDate":"2022-07-04","conditions":"Major Depression","enrollment":370212},{"nctId":"NCT04221997","phase":"PHASE4","title":"Trial With the Treatment of Sertraline in Youth With Generalized, Separation and/or Social Anxiety Disorders.","status":"RECRUITING","sponsor":"University of Cincinnati","startDate":"2019-11-01","conditions":"Anxiety Disorders","enrollment":150},{"nctId":"NCT00581009","phase":"PHASE1, PHASE2","title":"The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2001-05-30","conditions":"Major Depressive Disorder, Bipolar Disorder","enrollment":49},{"nctId":"NCT06580249","phase":"NA","title":"Efficacy and Mechanism of rTMS on the Symptoms of Pleasure Deficit in Adolescent Depression","status":"RECRUITING","sponsor":"Xijing Hospital","startDate":"2024-09-05","conditions":"Depression","enrollment":44},{"nctId":"NCT00836667","phase":"PHASE1","title":"Sertraline Hydrochloride 100 mg Tablets, Fed","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2002-03","conditions":"Healthy","enrollment":18},{"nctId":"NCT00836849","phase":"PHASE1","title":"Sertraline Hydrochloride 100 mg Tablets, Fasting","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2002-03","conditions":"Healthy","enrollment":24},{"nctId":"NCT05588102","phase":"NA","title":"Electronic Training of Elderly Depression With Cognitive Impairment","status":"COMPLETED","sponsor":"Capital Medical University","startDate":"2021-05-18","conditions":"Geriatric Depression, Cognitive Impairment","enrollment":128},{"nctId":"NCT06467474","phase":"NA","title":"Psychoeducational Group for Depression","status":"RECRUITING","sponsor":"Ricardo Alberto Moreno, M.D., Ph.D.","startDate":"2024-03-01","conditions":"Major Depressive Disorder (MDD","enrollment":338},{"nctId":"NCT02890212","phase":"NA","title":"Selenium as Augmentation Treatment for Sertraline Resistant Major Depression","status":"SUSPENDED","sponsor":"University of Sao Paulo General Hospital","startDate":"2005-08","conditions":"Major Depression","enrollment":60},{"nctId":"NCT05229302","phase":"NA","title":"Effectiveness of a CBT Online-based Program to Reduce Suicide Ideation Among School Adolescents","status":"COMPLETED","sponsor":"University of Talca","startDate":"2023-04-01","conditions":"Suicidal Ideation","enrollment":240},{"nctId":"NCT00648856","phase":"PHASE1","title":"Food Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2002-12","conditions":"Healthy","enrollment":21},{"nctId":"NCT00650325","phase":"PHASE1","title":"Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2002-11","conditions":"Healthy","enrollment":49},{"nctId":"NCT06363968","phase":"NA","title":"Biomarkers in the Retina for Prognosticating Mental Health Treatments","status":"RECRUITING","sponsor":"VA Puget Sound Health Care System","startDate":"2024-02-12","conditions":"PTSD, Posttraumatic Stress Disorder","enrollment":50},{"nctId":"NCT04478526","phase":"NA","title":"Efficacy of Online CBT for GAD Compared to Pharmaceutical Interventions","status":"COMPLETED","sponsor":"Dr. Nazanin Alavi","startDate":"2020-04-29","conditions":"Generalized Anxiety Disorder","enrollment":115},{"nctId":"NCT06357104","phase":"PHASE4","title":"Detoxification From the Lipid Tract","status":"COMPLETED","sponsor":"Pachankis, Yang I., M.D.","startDate":"2024-02-26","conditions":"COVID-19 Vaccine Adverse Reaction","enrollment":1},{"nctId":"NCT06358014","phase":"NA","title":"Assessment of the Improvement in Cognitive Levels of Postmenopausal Depression Patients by Estrogen","status":"RECRUITING","sponsor":"Xiao Wang","startDate":"2023-05-12","conditions":"Postmenopausal Depression, Estrogen","enrollment":40},{"nctId":"NCT06337539","phase":"","title":"Precision Psychiatry for Depression: Immune Response and Affective Symptoms as Predictors of Response to Antidepressants","status":"NOT_YET_RECRUITING","sponsor":"Germans Trias i Pujol Hospital","startDate":"2024-04-01","conditions":"Depression, Inflammation, Antidepressants","enrollment":50},{"nctId":"NCT05142683","phase":"NA","title":"Effectiveness of an Integrated Care Pathway for Depression: Cluster Randomized Controlled Trial","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2022-02-01","conditions":"Major Depressive Disorder","enrollment":300},{"nctId":"NCT04147000","phase":"","title":"Pharmacokinetics and Pharmacodynamics of Oral Sertraline Before and After Bariatric Surgery","status":"TERMINATED","sponsor":"Linkoeping University","startDate":"2020-01-01","conditions":"Overweight, Depression, Anxiety Disorders","enrollment":3},{"nctId":"NCT02893371","phase":"","title":"Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies","status":"TERMINATED","sponsor":"University of New Mexico","startDate":"2016-09","conditions":"Bipolar Disorder","enrollment":1037352},{"nctId":"NCT03993535","phase":"PHASE4","title":"Predicting Treatment Response in Patients With OCD","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2018-10-10","conditions":"Obsessive-Compulsive Disorder","enrollment":250},{"nctId":"NCT05720637","phase":"NA","title":"The Efficacy and Cerebral Mechanism of Intradermal Acupuncture for Major Depressive Disorder","status":"COMPLETED","sponsor":"Xiaomei Shao","startDate":"2022-11-01","conditions":"Major Depressive Disorder","enrollment":120},{"nctId":"NCT01437189","phase":"NA","title":"The Effects of Sertraline on Depression in Parkinson's Disease","status":"COMPLETED","sponsor":"Zhejiang University","startDate":"2011-08-01","conditions":"Depression, Parkinson's Disease","enrollment":35},{"nctId":"NCT05189977","phase":"PHASE1","title":"A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline","status":"TERMINATED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2022-09-07","conditions":"Post-traumatic Stress Disorder (PTSD)","enrollment":34},{"nctId":"NCT04476030","phase":"PHASE3","title":"A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive Disorder","status":"COMPLETED","sponsor":"Biogen","startDate":"2020-11-09","conditions":"Depressive Disorder, Major","enrollment":440},{"nctId":"NCT03279471","phase":"PHASE2","title":"Specifying and Treating Anxiety in Autism Research","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2017-10-01","conditions":"Autism Spectrum Disorder, Anxiety","enrollment":68},{"nctId":"NCT06124417","phase":"PHASE4","title":"Efficacy and Safety of Sertraline in the Treatment of Maintenance Hemodialysis Patients With Depression","status":"COMPLETED","sponsor":"First Affiliated Hospital of Chongqing Medical University","startDate":"2022-01-10","conditions":"Efficacy, Team, Adverse Reaction to Drug","enrollment":125},{"nctId":"NCT05544071","phase":"NA","title":"the Safety and Effectiveness of Precise rTMS Based on Neuroimaging in the Treatment of Adolescent Depression With Anhedoniadepression With Anhedonia","status":"UNKNOWN","sponsor":"Xijing Hospital","startDate":"2023-02-12","conditions":"Major Depressive Disorder, Repetitive Transcranial Magnetic Stimulation","enrollment":88},{"nctId":"NCT04437485","phase":"PHASE2","title":"eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk","status":"COMPLETED","sponsor":"Indiana University","startDate":"2020-10-14","conditions":"Depression, Major Depressive Disorder, Dysthymic Disorder","enrollment":46},{"nctId":"NCT02458690","phase":"PHASE2","title":"eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients","status":"COMPLETED","sponsor":"Indiana University","startDate":"2015-07","conditions":"Depression, Major Depressive Disorder, Dysthymic Disorder","enrollment":216},{"nctId":"NCT03538691","phase":"PHASE3","title":"A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2018-07-13","conditions":"Major Depressive Disorder","enrollment":1149},{"nctId":"NCT05241366","phase":"NA","title":"TMS vs Conventional Therapy for the Treatment of Functional Neurological Non Epileptic Seizure Disorder","status":"COMPLETED","sponsor":"El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez","startDate":"2022-02-14","conditions":"Psychogenic Non-Epileptic Seizure","enrollment":28},{"nctId":"NCT06035003","phase":"NA","title":"Mechanism of Mindfulness-Based Online Intervention in Enhancing Cognitive Flexibility","status":"UNKNOWN","sponsor":"Peking University","startDate":"2023-09-18","conditions":"Emotional Distress","enrollment":595},{"nctId":"NCT05889234","phase":"","title":"Multimodal Magnetic Resonance Imaging-based Study of Electroconvulsive Efficacy Prediction in Adolescents With Depression: a Multicenter Prospective Cohort Study","status":"UNKNOWN","sponsor":"First Affiliated Hospital of Chongqing Medical University","startDate":"2023-11-06","conditions":"Major Depressive Disorder, Magnetic Resonance Imaging, Electroconvulsive Therapy","enrollment":180},{"nctId":"NCT05931965","phase":"NA","title":"Combination Therapy of Different Antidepressants With Dietary Supplements","status":"COMPLETED","sponsor":"Riphah International University","startDate":"2022-10-05","conditions":"Depression","enrollment":88}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[{"date":"20211004","type":"ORIG","sponsor":"ALMATICA","applicationNumber":"NDA215133"},{"date":"20211004","type":"ORIG","sponsor":"ALMATICA","applicationNumber":"NDA215133"},{"date":"20230818","type":"SUPPL","sponsor":"ALMATICA","applicationNumber":"NDA215133"},{"date":"20260120","type":"ORIG","sponsor":"UMEDICA","applicationNumber":"ANDA218342"},{"date":"20260128","type":"ORIG","sponsor":"AMNEAL","applicationNumber":"ANDA219655"}],"publicationCount":17,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Zoloft"],"phase":"marketed","status":"active","brandName":"Sertraline HCl","genericName":"Sertraline HCl","companyName":"Tri-Service General Hospital","companyId":"tri-service-general-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sertraline HCl is a small molecule used to treat various conditions, including Major Depressive Disorder, Panic Disorder, and Myelodysplastic Syndromes, as well as sexual dysfunction associated with antidepressant use. It is a hydrochloride salt form of the medication Sertraline.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2021-10-04T00:00:00.000Z","mah":"ALMATICA","brand_name_local":null,"application_number":"NDA215133"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2026-01-20T00:00:00.000Z","mah":"UMEDICA","brand_name_local":null,"application_number":"ANDA218342"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2026-01-28T00:00:00.000Z","mah":"AMNEAL","brand_name_local":null,"application_number":"ANDA219655"}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}